Synaptic · 3 weeks ago
Territory Manager – Atlanta, GA – US
Synaptic is a company focused on medical device engineering, and they are seeking a Territory Manager to drive product adoption and market penetration in the Atlanta area. The role involves building relationships with healthcare providers and stakeholders to meet revenue targets while providing clinical support and developing strategic plans for growth.
BiotechnologyHealth CareMedical Device
Responsibilities
Leverage existing relationships with EP’s, healthcare providers, lab staff, and industry stakeholders to drive product adoption, market penetration and meet or exceed revenue targets in assigned territory
Educate customers and potential customers on the proper clinical usage of the products by way of product demonstrations and trial use cases
Provide regular clinical support to physicians to grow relationships and maintain product usage
Develop and utilize existing relationships with hospital personnel and identify decision makers in the purchasing process to facilitate sales
Develop plans to achieve aggressive growth targets, adapting to market dynamics
Develop KOLs in given territory
Maintain a deep understanding of Synaptic products, competitive landscape, and customer needs
Monitor and analyze market trends, competitor activities, and customer feedback to inform strategic decisions and optimize go-to-market efforts
Qualification
Required
2–5+ years of successful electrophysiology sales experience, with a strong track record of achieving or surpassing sales targets
Established, credible relationships with EPs in the region
Highly respected within the EP sales community; President's Club-level performance preferred
Willingness to travel frequently (3–5 days/week) for in-field support and case coverage
Passionate about electrophysiology and deep level of intellectual curiosity
Benefits
Medical
Dental
Vision
401(k)
PTO
Disability support
Company
Synaptic
We foster an empowering and nurturing platform, propelling our team members toward growth, while unwaveringly enhancing the prognosis of arrhythmia and related ailments.
Funding
Current Stage
Late StageTotal Funding
$100MKey Investors
C-Bridge CapitalHuagai Capital
2024-11-28Debt Financing· $40M
2021-03-25Series G· $60M
Leadership Team
Sophia Wang
Founder, Chairman, and CEO
Company data provided by crunchbase